AI Signal & Stock Analysis · Very Strong ↑
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for ARWR is Very Strong ↑; the stock is at $86.83 (+1.45% today); neutral (RSI 55); technical trend is Raise; news sentiment is positive.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Very Strong ↑ |
|---|---|
| Price | $86.83 |
| Change today | +1.45% |
| RSI (14) | 55.09 |
| Relative volume | 0.25 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $12.3B |
| Forward P/E | 0.00 |
| 52-week high | -9.1% away |
| 52-week low | +378.7% above |
| Technical trend | RAISE-2026-05-26 |
| News sentiment | Positive |
| Sector | Healthcare-Genetherapy |
| Next earnings | 8/4/2026 4:30:00 PM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns ARWR (Arrowhead Pharmaceuticals Inc) a Very Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
ARWR's RSI is neutral (RSI 55). A reading above 70 is typically considered overbought and below 30 oversold.
ARWR is trading about 9% below its 52-week high and 379% above its 52-week low as of Aug 14 2026, 1:04 PM.
ARWR's next earnings date is 8/4/2026 4:30:00 PM.
ARWR is classified under Healthcare-Genetherapy in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.